DUXAP9 and non-small cell lung carcinoma: Furthermore, through analysis of the correlation between DUXAP9‐206 level and clinicopathologic features of NSCLC patients from the SYSUCC cohort, we found that DUXAP9‐206 expression was significantly associated with T classification, LN metastasis and clinical stage demonstrating its relationship to tumour progression (Table S2).